NCT07842328

Brief Summary

Cerebral palsy can make it difficult for children and adolescents to participate consistently in enjoyable physical activity. This study will examine whether a small humanoid robot called NAO can deliver a short, story-based active-play session that encourages movement and participation. Children and adolescents with cerebral palsy will complete one session at BC Children's Hospital. The study will assess whether the intervention is practical to deliver, acceptable to children and caregivers, and safe to use. Participants and caregivers will also provide feedback about their experience. The findings will be used to refine the intervention and plan a future larger trial.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
14mo left

Started Oct 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
Oct 2026Dec 2027

First Submitted

Initial submission to the registry

September 14, 2026

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 25, 2026

Completed
6 days until next milestone

Study Start

First participant enrolled

October 1, 2026

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

September 25, 2026

Status Verified

September 1, 2026

Enrollment Period

1.2 years

First QC Date

September 14, 2026

Last Update Submit

September 21, 2026

Conditions

Keywords

Socially Assistive RobotHumanoid RobotNAO RobotActive PlayPediatric RehabilitationPhysical ActivityFeasibilityAcceptabilityHuman-Robot InteractionPediatrics

Outcome Measures

Primary Outcomes (4)

  • Recruitment Rate

    Number of child/adolescent participants enrolled relative to the prespecified recruitment target. Recruitment will be summarized descriptively. Progression will be interpreted as: target achieved = proceed; below target but recruitment achievable with an adjusted strategy or timeline = proceed with modification; below target with no feasible recruitment pathway = reconsider.

    From recruitment initiation through completion of enrollment, anticipated up to 15 months

  • Consent Rate

    Percentage of eligible child-caregiver dyads invited to participate who provide caregiver consent and child/adolescent assent and enroll in the study. Prespecified progression thresholds are ≥80% = proceed; 60-79% = proceed with modification; \<60% = reconsider.

    From recruitment initiation through completion of enrollment, anticipated up to 15 months

  • Session Completion Rate

    Percentage of enrolled child/adolescent participants who complete the planned NAO-guided active-play intervention session. Prespecified progression thresholds are ≥80% = proceed; 60-79% = proceed with modification; \<60% = reconsider.

    At completion of the approximately 12-minute intervention during the single study visit

  • Intervention Fidelity

    Fidelity to the prespecified NAO-guided intervention protocol will be assessed using the approved intervention fidelity checklist and summarized as a percentage. Prespecified progression thresholds are ≥80% = proceed; 60-79% = proceed with modification; \<60% = reconsider.

    At completion of the approximately 12-minute intervention during the single study visit

Secondary Outcomes (6)

  • Protocol Deviations

    At completion of the approximately 90-minute study visit (Day 1), based on deviations recorded throughout the visit

  • Adverse Events

    From enrollment through completion of the single study visit, approximately 90 minutes

  • REACT Post-Narrative Intervention Likert Scale: Child/Adolescent Engagement and Intention to Repeat

    Immediately following the intervention during the single study visit

  • REACT Caregiver Acceptability and Willingness Survey

    Immediately following the intervention during the single study visit

  • Participant-Reported Session Length and Sensor Comfort via REACT Facilitator Interview Guide

    During the approximately 30-minute post-intervention interview conducted during the single study visit

  • +1 more secondary outcomes

Other Outcomes (9)

  • OMNI Rating of Perceived Exertion Scale: Perceived Exertion

    Immediately following the approximately 12-minute intervention

  • Heart Rate Response

    During a 2-minute resting baseline and the approximately 12-minute intervention

  • Accelerometer-Derived Movement Output

    During the 2-minute seated resting baseline and the approximately 12-minute NAO-guided intervention during the single study visit

  • +6 more other outcomes

Study Arms (1)

NAO-Guided Active Play Intervention

EXPERIMENTAL

Participants will complete one in-person, NAO-delivered, movement-based narrative active-play session. The intervention includes parallel ambulatory (GMFCS I-III) and non-ambulatory (GMFCS IV) versions, with both versions sharing a common narrative structure and movement library.

Behavioral: Humanoid Robot-Guided Active Play Intervention

Interventions

A humanoid social robot (NAO, SoftBank Robotics) guides the participant through a single, story-based active-play session in which physical movements are embedded within a narrative. The intervention is designed to promote engagement and active participation rather than conventional prescriptive exercise delivery. Parallel ambulatory (GMFCS I-III) and non-ambulatory (GMFCS IV) versions are used, with both sharing a common narrative structure and movement library.

Also known as: REACT
NAO-Guided Active Play Intervention

Eligibility Criteria

Age6 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Children \& adolescents -
  • Aged 6-18 years with cerebral palsy
  • Gross Motor Function Classification System (GMFCS) Level I-IV
  • Sufficient receptive English language ability to follow simple verbal instructions from NAO and respond to interview questions, with or without caregiver or communication-aid support
  • Parent/caregiver -
  • Aged 19 years or older
  • Sufficient receptive English language ability to participate in interview and survey questions
  • Additional participation requirements -
  • Able to attend an in-person study visit at BC Children's Hospital
  • Enrollment is at the dyad level: each child/adolescent must participate with a parent/caregiver, and neither may participate independently

You may not qualify if:

  • GMFCS Level V
  • Uncontrolled seizure disorder or seizure within the previous 6 months
  • Severe visual or auditory impairment uncorrected by aids that would prevent interaction with NAO
  • Significant cognitive or communication impairment precluding assent and interview participation
  • Acute illness or cardiovascular condition contraindicating light-to-moderate physical activity
  • Additional consideration:
  • \- Individuals will be encouraged not to participate if the child or caregiver reports a fear of robots

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

BC Children's Hospital

Vancouver, British Columbia, V6H 3N1, Canada

Location

Related Publications (9)

  • Hennink M, Kaiser BN. Sample sizes for saturation in qualitative research: A systematic review of empirical tests. Soc Sci Med. 2022 Jan;292:114523. doi: 10.1016/j.socscimed.2021.114523. Epub 2021 Nov 2.

    PMID: 34785096BACKGROUND
  • Patel DR, Neelakantan M, Pandher K, Merrick J. Cerebral palsy in children: a clinical overview. Transl Pediatr. 2020 Feb;9(Suppl 1):S125-S135. doi: 10.21037/tp.2020.01.01.

    PMID: 32206590BACKGROUND
  • Sakzewski L, Reedman SE, Elliott C, Ziviani J, Novak I, Trost S, Majnemer A, Comans T, Shikako K, Ware RS, McNamara L, Williams S, Keramat SA, Brookes D, Boyd RN. Participate CP 2: optimising participation in physically active leisure for children with cerebral palsy - protocol for a phase III randomised controlled trial. BMJ Open. 2023 Oct 3;13(10):e075570. doi: 10.1136/bmjopen-2023-075570.

    PMID: 37788925BACKGROUND
  • Avery KN, Williamson PR, Gamble C, O'Connell Francischetto E, Metcalfe C, Davidson P, Williams H, Blazeby JM; members of the Internal Pilot Trials Workshop supported by the Hubs for Trials Methodology Research. Informing efficient randomised controlled trials: exploration of challenges in developing progression criteria for internal pilot studies. BMJ Open. 2017 Feb 17;7(2):e013537. doi: 10.1136/bmjopen-2016-013537.

    PMID: 28213598BACKGROUND
  • Verschuren O, Peterson MD, Balemans AC, Hurvitz EA. Exercise and physical activity recommendations for people with cerebral palsy. Dev Med Child Neurol. 2016 Aug;58(8):798-808. doi: 10.1111/dmcn.13053. Epub 2016 Feb 7.

    PMID: 26853808BACKGROUND
  • Fragala-Pinkham M, O'Neil ME, Lennon N, Forman JL, Trost SG. Validity of the OMNI rating of perceived exertion scale for children and adolescents with cerebral palsy. Dev Med Child Neurol. 2015 Aug;57(8):748-53. doi: 10.1111/dmcn.12703. Epub 2015 Jan 27.

    PMID: 25627218BACKGROUND
  • Buitrago JA, Bolanos AM, Caicedo Bravo E. A motor learning therapeutic intervention for a child with cerebral palsy through a social assistive robot. Disabil Rehabil Assist Technol. 2020 Apr;15(3):357-362. doi: 10.1080/17483107.2019.1578999. Epub 2019 Feb 26.

    PMID: 30806105BACKGROUND
  • Lancaster GA, Thabane L. Guidelines for reporting non-randomised pilot and feasibility studies. Pilot Feasibility Stud. 2019 Oct 6;5:114. doi: 10.1186/s40814-019-0499-1. eCollection 2019.

    PMID: 31608150BACKGROUND
  • Bowen DJ, Kreuter M, Spring B, Cofta-Woerpel L, Linnan L, Weiner D, Bakken S, Kaplan CP, Squiers L, Fabrizio C, Fernandez M. How we design feasibility studies. Am J Prev Med. 2009 May;36(5):452-7. doi: 10.1016/j.amepre.2009.02.002.

    PMID: 19362699BACKGROUND

MeSH Terms

Conditions

Cerebral PalsyMotor Activity

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesBehavior

Study Officials

  • Julie Robillard, PhD

    University of British Columbia

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jordan Stevenson, MSc

CONTACT

Julie Robillard, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Neurology

Study Record Dates

First Submitted

September 14, 2026

First Posted

September 25, 2026

Study Start

October 1, 2026

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2027

Last Updated

September 25, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be made available to external researchers. Study data will be de-identified and stored securely on UBC OneDrive, with access limited to the research team, and retained for five years after publication in accordance with the approved ethics protocol.

Locations